HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
At HTL, we continuously explore groundbreaking applications for HA that extend far beyond today’s horizons.
We are continusly investing in innovation and improving the abilities of our premium Hyaluronic Acid to make it work better for future uses.
Caroline Robic, Innovation Director
“Due to their incredible properties, biopolymers are already key components for aesthetics, ophthalmology, and rheumatology areas.
At HTL, we really believe that they will soon play a key role in new indications like Oncology or vaccines.”